JPRN-UMIN000037697招募中未知
Diagnostic Performance of PET Imaging for Prostate Specific Membrane Antigen (PSMA) - Diagnostic Performance of PSMA-PET
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 250
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- Male
入选标准
- 未提供
排除标准
- •(1) Patient who cannot keep the body position for 30 minutes. (2) Others who are regarded as unsuitable for enrollment in the opinion of research staff.
研究者
相似试验
进行中（未招募）
1 期
Imaging of the prostate tumors using PET/CT and PET/MRI with the ligand of the prostatic specific membrane antigene 68Ga-PSMA-11prostatic carcinoma higly suspected or its staging or restagingEUCTR2017-004128-32-CZFakultní nemocnice Plzen200
招募中
不适用
Evaluation of new PET tracer, [F-18]Florastamin for diagnosing prostate cancer: Phase I clinical trialKCT0004817FutureChem10
招募中
不适用
Diagnostic performance of Prostate HistoScanningTM (PHS) in men at risk of prostate cancer scheduled for an initial prostate biopsy.Subjects suspected to have PCa who are schedules for a first prostate biopsy.C61Malignant neoplasm of prostateDRKS00005263Advanced Medical Diagnostics SAWaterloo Office Park Bât i bte 3391
招募中
不适用
Evaluation of new PET tracer, [F-18]Florastamin for diagnosing prostate cancerNeoplasmsKCT0003924Korea Cancer Center Hospital6
进行中（未招募）
1 期
18F-PSMA PET in primary prostate cancer.75 patients with the suspicion on PCa (elevated PSA and/or abnormal digital rectal exam) will receive a PSMA-PET following mpMRI. 25 patients with PIRADS 1-2 (probably benign disease), 25 patients with PIRADS 3 (equivocal disease) and 25 patients with PIRADS 4-5 (highly suspicious for malignancy) will be included in this explorative study.MedDRA version: 20.0Level: LLTClassification code 10036921Term: Prostate carcinomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 20.0Level: PTClassification code 10060862Term: Prostate cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2020-001387-28-NLRadboud University Medical Center75